---
handoff_id: "CR172-CP5-INDEPENDENT-LLD-REVIEW-R2"
change_id: "CR-172"
checkpoint: "CP5"
canonical_role: "meta-qa"
codex_agent_name: "meta-qa-critical"
reasoning_profile: "critical"
context_ref: "process/context/CP5-CR172-PATH-I-LLD-CONTEXT.yaml"
r1_findings_ref: "process/checks/CP5-CR172-LLD-REVIEW-R1-FINDINGS.md"
r2_correlation_ref: "process/checks/CP5-CR172-LLD-R2-CROSS-CONTRACT-CORRELATION.result.json"
status: "ready"
---

# CR-172 CP5 Independent LLD Review R2

独立复审五份 LLD v1.1 及其 HLD/ADR/Feature/Story/Plan R2 基线。必须逐项判定 R1 F-001～F-005 是否关闭，并重点查找新缺陷：

1. 不得把现有 mature runner 或 `forward_label_proxy@v1` 恢复成真实 trial-return；runner/lineage planned diff 应为 0/0。
2. partial lineage 只能是 BLOCKED audit，不得承诺擦除、fail() 伪回滚或成功痕迹归零。
3. S01 approval record 精确 12 fields；fixture/real typed binding 必须在 first side effect 前可编码地拒绝。
4. S02→S03 exact public symbol、seal digest/hash domain/verifier/result 必须是单一真相；S03 不得生成 secondary digest。
5. S03→S04 receipt/selection/origin/target/digest 必须精确衔接；S04 test ID=16/16/0。
6. S05 不得通过读取/执行 runner 源码来证明零差异；应消费 CP6/CP7 change-scope evidence，并保持真实动作/claims 为零/false。

使用 review-artifact-protocol 输出并校验：

- `process/checks/CP5-CR172-LLD-REVIEW-R2-FINDINGS.md`
- `process/checks/CP5-CR172-LLD-REVIEW-R2-SUMMARY.md`
- `process/handoffs/CR172-CP5-INDEPENDENT-LLD-REVIEW-R2-META-QA-CRITICAL-RETURN-SUMMARY.md`

只读审查；不得修改任何设计、LLD、源码、测试、fixture、state、ledger 或 checkpoint。只有 blocking=0 且 required=0 才允许 `decision=proceed`。
